These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3987027)

  • 1. Confirmation of serum salicylate levels in Reye's syndrome: a comparison between the Natelson colorimetric method and high performance liquid chromatography.
    Clark JH; Nagamori K; Fitzgerald JF
    Clin Chim Acta; 1985 Feb; 145(3):243-7. PubMed ID: 3987027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum salicylate concentrations in Reye's disease. A study of 130 biopsy-proven cases.
    Partin JS; Partin JC; Schubert WK; Hammond JG
    Lancet; 1982 Jan; 1(8265):191-4. PubMed ID: 6119559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of true salicylate concentrations in serum from patients with Reye's syndrome.
    Kang ES; Todd TA; Capaci MT; Schwenzer K; Jabbour JT
    Clin Chem; 1983 Jun; 29(6):1012-4. PubMed ID: 6851086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reye's syndrome in the United States from 1981 through 1997.
    Belay ED; Bresee JS; Holman RC; Khan AS; Shahriari A; Schonberger LB
    N Engl J Med; 1999 May; 340(18):1377-82. PubMed ID: 10228187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome.
    Partin JS; Daugherty CC; McAdams AJ; Partin JC; Schubert WK
    Hepatology; 1984; 4(4):687-90. PubMed ID: 6745858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylate and Reye's syndrome.
    Rodgers GC; Weiner LB; McMillan JA
    Lancet; 1982 Mar; 1(8272):616. PubMed ID: 6121196
    [No Abstract]   [Full Text] [Related]  

  • 7. Public Health Service study of Reye's syndrome and medications. Report of the main study.
    Hurwitz ES; Barrett MJ; Bregman D; Gunn WJ; Pinsky P; Schonberger LB; Drage JS; Kaslow RA; Burlington DB; Quinnan GV
    JAMA; 1987 Apr; 257(14):1905-11. PubMed ID: 3820509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.
    Sillanpää M; Mäkelä AL; Koivikko A
    Acta Paediatr Scand; 1975 Nov; 64(6):877-80. PubMed ID: 1189911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma salicylate analysis: a comparison of colorimetric, HPLC and enzymatic techniques.
    Jarvie DR; Heyworth R; Simpson D
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():364-73. PubMed ID: 3662387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylate and mitochondrial monoamine oxidase function in Reye's syndrome.
    Faraj BA; Caplan D; Lolies P; Buchanan C
    J Pharm Sci; 1987 Jun; 76(6):423-6. PubMed ID: 3625483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reye's and Reye's-like syndromes.
    Pugliese A; Beltramo T; Torre D
    Cell Biochem Funct; 2008 Oct; 26(7):741-6. PubMed ID: 18711704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reye's syndrome--a severe complication of salicylate therapy].
    Vengerovskiĭ AI; Baturina NO; Saratikov AS
    Eksp Klin Farmakol; 2000; 63(2):76-80. PubMed ID: 10834102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and encephalopathic components of Reye's syndrome: factor analysis of admission data from 209 patients.
    Mitchell RA; Partin JC; Partin JS; Ram ML
    Neurology; 1985 Aug; 35(8):1236-9. PubMed ID: 4022364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aspirin a cause of Reye's syndrome? A case against.
    Orlowski JP; Hanhan UA; Fiallos MR
    Drug Saf; 2002; 25(4):225-31. PubMed ID: 11994026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reye's syndrome. Salicylate metabolism, viral antibody levels, and other factors in surviving patients and unaffected family members.
    Chu AB; Nerurkar LS; Witzel N; Andresen BD; Alexander M; Kang ES; Brouwers P; Fedio P; Lee YJ; Sever JL
    Am J Dis Child; 1986 Oct; 140(10):1009-12. PubMed ID: 3019125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome.
    Trost LC; Lemasters JJ
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):431-41. PubMed ID: 9439738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired oxidative metabolism of salicylate in Reye's syndrome.
    Meert KL; Kauffman RE; Deshmukh DR; Sarnaik AP
    Dev Pharmacol Ther; 1990; 15(2):57-60. PubMed ID: 2078973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reye's syndrome: mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate.
    Martens ME; Chang CH; Lee CP
    Arch Biochem Biophys; 1986 Feb; 244(2):773-86. PubMed ID: 3080954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reye's syndrome and salicylate use.
    Starko KM; Ray CG; Dominguez LB; Stromberg WL; Woodall DF
    Pediatrics; 1980 Dec; 66(6):859-64. PubMed ID: 7454476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reye's syndrome: salicylates and mitochondrial functions.
    Martens ME; Lee CP
    Biochem Pharmacol; 1984 Sep; 33(18):2869-76. PubMed ID: 6477646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.